Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)
Phase I/II Study of Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)
Sponsor: National Cancer Institute (NCI)
Listed as NCT04086485, this PHASE1/PHASE2 trial focuses on Gastroenteropancreatico Tumors and Neuroendocrine Neoplasms and remains actively recruiting participants. Sponsored by National Cancer Institute (NCI), it has been updated 64 times since 2022, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
64 versions recorded-
Jan 2026 — Present [monthly]
Recruiting PHASE1/PHASE2
-
Dec 2025 — Jan 2026 [monthly]
Recruiting PHASE1/PHASE2
-
Nov 2025 — Dec 2025 [monthly]
Recruiting PHASE1/PHASE2
-
Oct 2025 — Nov 2025 [monthly]
Recruiting PHASE1/PHASE2
-
Sep 2025 — Oct 2025 [monthly]
Recruiting PHASE1/PHASE2
▶ Show 59 earlier versions
-
Aug 2025 — Sep 2025 [monthly]
Recruiting PHASE1/PHASE2
-
Jul 2025 — Aug 2025 [monthly]
Recruiting PHASE1/PHASE2
-
Jun 2025 — Jul 2025 [monthly]
Recruiting PHASE1/PHASE2
-
May 2025 — Jun 2025 [monthly]
Recruiting PHASE1/PHASE2
-
Apr 2025 — May 2025 [monthly]
Recruiting PHASE1/PHASE2
-
Mar 2025 — Apr 2025 [monthly]
Recruiting PHASE1/PHASE2
-
Feb 2025 — Mar 2025 [monthly]
Recruiting PHASE1/PHASE2
-
Jan 2025 — Feb 2025 [monthly]
Recruiting PHASE1/PHASE2
-
Dec 2024 — Jan 2025 [monthly]
Recruiting PHASE1/PHASE2
-
Oct 2024 — Dec 2024 [monthly]
Recruiting PHASE1/PHASE2
-
Sep 2024 — Oct 2024 [monthly]
Recruiting PHASE1/PHASE2
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE1/PHASE2
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jun 2024 — Jul 2024 [monthly]
Recruiting PHASE1_PHASE2
-
May 2024 — Jun 2024 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2024 — May 2024 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2024 — Mar 2024 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2023 — Feb 2024 [monthly]
Recruiting PHASE1_PHASE2
-
Jul 2023 — Oct 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2023 — Jul 2023 [monthly]
Recruiting PHASE1_PHASE2
-
May 2023 — Jun 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Apr 2023 — May 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2023 — Apr 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2023 — Mar 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Nov 2022 — Feb 2023 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2022 — Nov 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Sep 2022 — Oct 2022 [monthly]
Recruiting PHASE1_PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jul 2022 — Sep 2022 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Jun 2022 — Jul 2022 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
May 2022 — Jun 2022 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Apr 2022 — May 2022 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Mar 2022 — Apr 2022 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Feb 2022 — Mar 2022 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Jan 2022 — Feb 2022 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Dec 2021 — Jan 2022 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Nov 2021 — Dec 2021 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Oct 2021 — Nov 2021 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Sep 2021 — Oct 2021 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Jun 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
May 2021 — Jun 2021 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Apr 2021 — May 2021 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Mar 2021 — Apr 2021 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Feb 2021 — Mar 2021 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Nov 2020 — Dec 2020 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Oct 2020 — Nov 2020 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Sep 2020 — Oct 2020 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Aug 2020 — Sep 2020 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Jul 2020 — Aug 2020 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Jun 2020 — Jul 2020 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
May 2020 — Jun 2020 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Apr 2020 — May 2020 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Mar 2020 — Apr 2020 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Feb 2020 — Mar 2020 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Jan 2020 — Feb 2020 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Dec 2019 — Jan 2020 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Nov 2019 — Dec 2019 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Oct 2019 — Nov 2019 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .